These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 8285162
1. [Results of combination chemotherapy with etoposide, ifosfamide, peplomycin for advanced prostatic cancer]. Ushiyama T, Ihara H, Kurita Y, Kageyama S, Ueda D, Mugiya S, Yamaguchi Y, Nakano M, Suzuki K, Kawabe K. Hinyokika Kiyo; 1993 Dec; 39(12):1139-44. PubMed ID: 8285162 [Abstract] [Full Text] [Related]
2. [Combination chemotherapy with ifosfamide (or cyclophosphamide), adriamycin, cis-platinum and peplomycin (IAPP) for hormonally resistant metastatic prostatic cancer]. Maeda O, Saiki S, Kinouchi T, Kuroda M, Miki T, Usami M, Kotake T. Hinyokika Kiyo; 1991 Dec; 37(12):1657-62. PubMed ID: 1723841 [Abstract] [Full Text] [Related]
3. [Combination chemotherapy with ifosfamide, 5-fluorouracil, cisplatin for stage D2 prostatic cancer]. Takeuchi S, Fukui I, Higashi Y, Andoh M, Kihara K, Kitahara S, Horiuchi S, Oshima H. Hinyokika Kiyo; 1989 Sep; 35(9):1513-7. PubMed ID: 2816618 [Abstract] [Full Text] [Related]
4. [Clinical evaluation of chemohormonal therapy as an initial treatment for stage D2 prostatic cancer--effect of UFT administration combined with hormonal therapy]. Honda M, Takasaki E, Suzuki T, Maeda S, Imai T, Hosoya Y, Chen JA. Gan To Kagaku Ryoho; 1995 Jan; 22(1):105-9. PubMed ID: 7826063 [Abstract] [Full Text] [Related]
5. [Alternating combination chemotherapy (VIP-DMF) in patients with advanced adenocarcinoma of the prostate]. Yoshimoto J, Ochi J, Tanahashi T, Nanba K, Saegusa M, Hara M, Akagi T, Obama T, Tsushima T, Ozaki Y. Gan To Kagaku Ryoho; 1987 Feb; 14(2):434-9. PubMed ID: 2434029 [Abstract] [Full Text] [Related]
6. [Treatment of hormonal refractory adenocarcinoma of the prostate with ifosfamide (IFM) and the combination of vincristine ifosfamide and peplomycin (VIP)]. Nukui M, Nakao M, Nakagawa S, Toyoda K, Takada H, Ebisui K, Watanabe H, Miyakoda K, Kobayashi T, Fujiwara M. Hinyokika Kiyo; 1989 Mar; 35(3):415-20. PubMed ID: 2472052 [Abstract] [Full Text] [Related]
7. [Hormonal treatment of carcinoma of the prostate]. Obata K, Kobayashi H, Murase T, Ohisi M. Hinyokika Kiyo; 1991 Aug; 37(8):809-16. PubMed ID: 1720272 [Abstract] [Full Text] [Related]
15. [Reactivation of prostatic cancer and chemotherapy in reactivated prostatic cancer]. Fuse H, Ando K, Hara S, Zama S, Shimazaki J. Hinyokika Kiyo; 1985 Feb; 31(2):281-7. PubMed ID: 2409787 [Abstract] [Full Text] [Related]
16. Successful treatment of poor prognostic patients with advanced prostatic carcinoma with the association of diethylstilbestrol and cyclophosphamide. Germá Lluch JR, Marcuello Gaspar E, de Andrés Basauri L, López Pousa A, López López JJ. Rev Esp Oncol; 1982 Feb; 29(2):317-24. PubMed ID: 7188232 [Abstract] [Full Text] [Related]
19. Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer. Azuma H, Sakamoto T, Kiyama S, Ubai T, Kotake Y, Inamoto T, Takahara K, Nishimura Y, Segawa N, Katsuoka Y. Am J Clin Oncol; 2008 Apr; 31(2):188-94. PubMed ID: 18391605 [Abstract] [Full Text] [Related]
20. [Combined hormone and chemotherapy for the patients with advanced prostate cancer]. Uekado Y, Hirano A, Inagaki T, Hiroi A, Watanabe T. Gan To Kagaku Ryoho; 1995 Jul; 22(8):1041-5. PubMed ID: 7611755 [Abstract] [Full Text] [Related] Page: [Next] [New Search]